Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Clinical trial NCT04056182 · COMPLETED

Trial details

NCT number: NCT04056182
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid-use Disorder

Start date: 2019-09-01
Primary completion: 2021-01-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.